BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28686636)

  • 1. Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.
    Tweya H; Feldacker C; Heller T; Gugsa S; Ng'ambi W; Nthala O; Kalulu M; Chiwoko J; Banda R; Makwinja A; Phiri S
    PLoS One; 2017; 12(7):e0180232. PubMed ID: 28686636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling adverse treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics in Lusaka.
    Fwemba I; Musonda P
    Public Health; 2017 Jun; 147():8-14. PubMed ID: 28404502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.
    Weigel R; Estill J; Egger M; Harries AD; Makombe S; Tweya H; Jahn A; Keiser O
    AIDS; 2012 Jan; 26(3):365-73. PubMed ID: 22095194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
    Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
    PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
    Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
    Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve EN; Kayabu D; Nassari NO; Todd J
    Trop Med Int Health; 2015 Jun; 20(6):791-6. PubMed ID: 25706518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
    Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
    J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in nutritional, functional and immunological status of HIV-infected adults with antiretroviral therapy.
    Tafese Z; Berhan Y; Abebe H
    Ethiop Med J; 2012 Jan; 50(1):75-87. PubMed ID: 22519164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
    Gezie LD
    BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi.
    Johnson DC; Feldacker C; Tweya H; Phiri S; Hosseinipour MC
    Int J STD AIDS; 2013 Jan; 24(1):42-9. PubMed ID: 23467293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival in HIV treatment programmes in Asia.
    De La Mata NL; Kumarasamy N; Khol V; Ng OT; Van Nguyen K; Merati TP; Pham TT; Lee MP; Durier N; Law M
    Antivir Ther; 2016; 21(6):517-527. PubMed ID: 26961354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.
    Mutevedzi PC; Lessells RJ; Rodger AJ; Newell ML
    PLoS One; 2011; 6(7):e21795. PubMed ID: 21747959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.